SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-016007
Filing Date
2021-04-15
Accepted
2021-04-15 19:00:50
Documents
2
Period of Report
2021-04-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1648
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4600
  Complete submission text file 0000899243-21-016007.txt   7639
Mailing Address ONE HAMDEN CENTER 2319 WHITNEY AVENUE, SUITE 3B HAMDEN CT 06518
Business Address
Galletta Christopher (Reporting) CIK: 0001486099 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38886 | Film No.: 21829738

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations